BiotechTube
Home/Angitia Biopharmaceuticals/Hua Zhu (David) Ke, MD
HZ

Hua Zhu (David) Ke, MD

Founder, Chairman, Chief Executive Officer

Angitia Biopharmaceuticals

Therapeutic Areas

Musculoskeletal DiseasesOsteoporosisOsteogenesis ImperfectaSpinal Disorders

Angitia Biopharmaceuticals Pipeline

DrugIndicationPhase
AGA2118OsteoporosisPhase 2
AGA2115Osteogenesis ImperfectaPhase 2
AGA111Spinal FusionPhase 3